Vanguard Personalized Indexing Management, LLC C4 Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 14,720 shares of CCCC stock, worth $36,211. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,720
Previous 19,595
24.88%
Holding current value
$36,211
Previous $31,000
32.26%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CCCC
# of Institutions
103Shares Held
57.2MCall Options Held
15.2KPut Options Held
0-
Wasatch Advisors Inc Salt Lake City, UT7.42MShares$18.3 Million0.06% of portfolio
-
Lynx1 Capital Management LP San Juan, PR7.1MShares$17.5 Million3.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT6.98MShares$17.2 Million0.77% of portfolio
-
Orbimed Advisors LLC San Diego, CA6.83MShares$16.8 Million0.35% of portfolio
-
Morgan Stanley New York, NY4.75MShares$11.7 Million0.0% of portfolio
About C4 Therapeutics, Inc.
- Ticker CCCC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,913,800
- Market Cap $120M
- Description
- C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...